Amferia’s technology is born out of years of research performed at Chalmers University of Technology. The concept behind Amferia’s antibacterial properties are enabled by a new material known as amphiphilic antimicrobial hydrogel.
An amphiphilic substance is one that displays both hydrophilic and hydrophobic characteristics. Comprised of about 70% water, the hydrogel is soft and flexible, making it useful for numerous medical applications.
Amferia’s technology is based on a new material known as amphiphilic antimicrobial hydrogels
The surface of amphiphilic hydrogel consists of antimicrobial peptides that are covalently and permanently bound to the hydrogels amphiphilic structure—forming a single material. The material interacts with bacterial cells and, disrupts the bacterial cell wall rapidly, effectively killing the bacteria.
Testing proves that the amphiphilic antimicrobial hydrogel does not release any substances into the wound or the environment. This material can potentially be configured into antimicrobial products ranging from wound care dressings to antiseptic sprays to mechanically durable devices such as catheters and implants.
To date, analysis confirms that Amferia amphiphilic hydrogel reduces microbial growth by 99.99% which includes gram-negative and gram-positive bacteria, and fungi.
It has been proven to be non-toxic to the body as per ISO 10993 biocompatibility evaluations, namely acute toxicity, cytotoxicity, skin sensitisation & irritation, implantation and material mediated pyrogenicity.
Amferia's first product for human wound care has been developed for easy applicability and functionality. More products and broader applications are in the pipeline.
